-
Measuring and predicting the effect of remyelinating therapy in multiple sclerosis: a randomised controlled trial protocol (RESTORE)
Hof, S., van Rijn, L. J., Uitdehaag, B. M. J., Nij Bijvank, J. A. & Petzold, A., 30 Jan 2024, In: BMJ Open. 14, 1, p. e076651 e076651.Research output: Contribution to journal › Article › Academic › peer-review
-
A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage
Nij Bijvank, J. A., Hof, S. N., Prouskas, S. E., Schoonheim, M. M., Uitdehaag, B. M. J., van Rijn, L. J. & Petzold, A., 1 Jun 2023, In: Brain. 146, 6, p. 2476-2488 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
The evolution of internuclear ophthalmoparesis in multiple sclerosis: a one year follow-up study
Hof, SN., Molenaar, PCG., Nij Bijvank, JA., Lam, KH., van Rijn, LJ., Petzold, AFS., Killestein, J. & Uitdehaag, BMJ., 12 Oct 2022, p. 692-945.Research output: Contribution to conference › Poster › Academic
- All publications